Concepedia

Mary J. Harner

MJ

4

Publications

161

Citations

4

H-Index

2014

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Mary J. Harner is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicine, and drug design.

Top concepts

MedicineDrug DiscoveryDrug DesignBiochemistryPharmacologyDrug AnalysisNatural SciencesMolecular BiologyMagnetic ResonanceRadiation Oncology

Publications per year

2014–2022

4

Publications

4

Fragment-Based Screening of the Bromodomain of ATAD2

Mary J. Harner, Brian A. Chauder, Jason Phan et al. · Journal of Medicinal Chemistry · 2014 · 82 citations · Full text

Fragment Screen, Molecular Characterization, Fragment Hits +12

Discovery of Non-Nucleotide Small-Molecule STING Agonists <i>via</i> Chemotype Hybridization

Emily C. Cherney, Liping Zhang, Julian B. Lo et al. · Journal of Medicinal Chemistry · 2022 · 31 citations · Full text

NMR in drug design

Mary J. Harner, Luciano Mueller, Kevin J. Robbins et al. · Archives of Biochemistry and Biophysics · 2017 · 26 citations

Magnetic Resonance Spectroscopy, Drug Design, Medicine +6

A Selection of Macrocyclic Peptides That Bind STING From an mRNA‐Display Library With Split Degenerate Codons

Chi‐Wang Lin, Mary J. Harner, Andrew Douglas et al. · Angewandte Chemie International Edition · 2021 · 22 citations · Full text

Rows per page

1–4 of 4